FdaApplication
ANDA 213513
Identifiers
- fda_app_no: ANDA213513
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2020-04-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVOCETIRIZINE DIHYDROCHLORIDE | LEVOCETIRIZINE DIHYDROCHLORIDE | 5MG | TABLET;ORAL |
1 product